Abstract
To elucidate the neurochemical mechanism that underlies the effect of anti-parkinsonian agents on motor activities in the dopamine-depleted striatum, we evaluated AP-I and CREB DNA-binding activity in the striatum of 6-hydroxydopamine-lesioned rats by use of a gel mobility-shift assay. Rats with a unilateral lesion of the nigrostriatal dopamine pathway were injected i.p. with either SKF38393 (a DI receptor agonist), bromocriptine (a D2 receptor agonist), or levodopa (a Dl/D2 receptor agonist). Each treatment increased the number of rotational responses of rats contralateral to the lesioned side. However, only SKF38393 and levodopa increased AP-I and CREB DNA-binding activity in the dopamine-depleted striatum. As with the expression of c-fos, supersensitive DI receptors may play a key role in the enhanced induction of AP-I and CREB DNA-binding activity in the dopamine-depleted striatum. Supershift analysis revealed that c-Fos; and Jun family proteins are the main components for AP-1 induced in the dopamine-depleted striaturn by SKF38393 or levodopa.
References
Apr 1, 1992·Journal of Neurochemistry·A J ColeJ M Baraban
Jan 1, 1992·European Neurology·T NakanishiA Takahashi
Jun 7, 1991·Science·M ShengM E Greenberg
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·T Hai, T Curran
Dec 7, 1990·Science·C R GerfenD R Sibley
Dec 4, 1989·Brain Research·H A RobertsonG S Robertson
Nov 17, 1989·Cell·G A Gonzalez, M R Montminy
Nov 4, 1988·Cell·T Curran, B R Franza
May 1, 1987·Neurology·U K Rinne
Feb 13, 1969·The New England Journal of Medicine·G C CotziasR Gellene
Jan 1, 1981·Experientia·M Baudysová, J Michl
Sep 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·J L MontastrucA Rascol
Mar 1, 1993·Neuroscience·R JenkinsS P Hunt
Oct 1, 1997·Neuroscience·K KashiharaT Shomori
Aug 24, 2012·Journal of Experimental Botany·Christine ZawaskiVictor B Busov
Citations
Nov 9, 2000·Neuroscience Research·K KashiharaK Abe
Dec 31, 2003·Experimental Neurology·Paula RavenscroftAlan R Crossman
Oct 6, 2009·Pharmacology, Biochemistry, and Behavior·Alexia E Pollack, Lindsay I Thomas
Mar 11, 1999·Experimental Neurology·B HenryJ M Brotchie
Nov 21, 2000·Annals of the New York Academy of Sciences·M A Hebert, J P O'Callaghan
Sep 28, 2004·Brain Pathology·Takao Nakagawa, Joan P Schwartz
Jan 1, 1996·Life Sciences·K KashiharaT Shohmori